Alteration of histological gastritis after cure of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 11, 2002, Pages 1923-1932

  Hojo, M ^a   Miwa, H ^a   Ohkusa, T ^a   Ohkura, R ^a   Kurosawa, A ^a   Sato, N ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATROPHIC GASTRITIS; DATA ANALYSIS; DISEASE ACTIVITY; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTESTINE METAPLASIA; MEDICAL LITERATURE; MEDLINE; PATIENT SELECTION; PRIORITY JOURNAL; SAMPLE SIZE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METAPLASIA; TREATMENT OUTCOME;

EID: 0036829450     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01346.x     Document Type: Article

References (65)

1. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-12.
2. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116: 705-8.
3. Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
4. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
5. Kyzekova J, Mour J. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. Hepatogastroenterology 1999; 46: 2048-56.
6. Price AB. The Sydney system: Histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
7. Dixon MF. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996; 201: 1161-81.
8. Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 380-6.
9. Orihara T, Wakabayashi H, Nakaya A, et al. Effect of Helicobacter pylori eradication on gastric mucosal phospholipid content and its fatty acid composition. J Gastroenterol Hepatol 2001; 16: 269-75.
10. Kimura A, Tsuji S, Tsujii M, et al. Expression of cyclooxygenase-2 and nitrotyrosine in human gastric mucosa before and after Helicobacter pylori eradication. Prostaglandins Leukot Essent Fatty Acids 2000; 63: 315-22.
11. Sung JJY, Lin S, Ching JYL, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study. Gastroenterology 2000; 119: 7-14.
12. Annibale B, Rosaria Aprile M, D'ambra G, Caruana P, Bordi C, Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000; 14: 625-34.
13. Miwa H, Hirai S, Nagahara A, et al. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients - A double-blind placebo-controlled study. Aliment Pharmacol Ther 2000; 14: 317-24.
14. Hsu P, Lai K, Tseng H, et al. Impact of Helicobacter pylori eradication on the development of MALT. gland atrophy and intestinal metaplasia of the antrum. Chin Med J (Taipei) 2000; 63: 279-87.
15. Rollan A, Giancaspero R, Fuster F, et al. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am J Gastroenterol 2000; 95: 50-6.
16. Abdul Aal GM, Dajani AI, Nounou M, et al. Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week. Digestion 1999; 60: 286-97.
17. Tepeš B, Kavčič B, Zaletel LK, et al. Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication. J Pathol 1999; 188: 24-9.
18. Zerbib F, Lenk C, Sawan B, et al. Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients. Eur J Gastroenterol Hepatol 2000; 12: 719-25.
19. Savarino V, Mela GS, Zentilin P, et al. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol 1999; 31: 4-8.
20. Talley NJ, Vakil N, Ballard ED II, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999; 341: 1106-11.
21. Satoh K, Kimura K, Takimoto T, Kihira K. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998; 3: 236-40.
22. Oberhuber G, Wuendisch T, Rappel S, Stolte M. Significant improvement of atrophy after eradication therapy in atrophic body gastritis. Pathology 1998; 194: 609-13.
23. Furuta T, Baba M, Takashima H, et al. Effect of Helicobacter pylori infection on gastric juice pH. Scand J Gastroenterol 1998; 33: 357-63.
24. Adamek RJ, Pfaffenbach B, Szymanski C, Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics, Helicobacter 1998; 3: 206-11.
25. Tucci A, Poll L, Tosetti C, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998; 93: 1425-31.
26. Yang HB, Sheu BS, Su IJ, Chien CH, Lin XZ. Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication. Dig Dis Sci 1997; 42: 1835-40.
27. Van Der Hulst RWM, Van der Ende A, Dekker FW, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: A prospective 1-year follow-up study. Gastroenterology 1997; 113: 25-30.
28. Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer. Am J Gastroenterol 1997; 92: 1844-8.
29. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-42.
30. Gisberd JP, Boixeda D, de Argila CM, Bermejo F, Redondo C, de Rafael L. Erosive duodenitis: Prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics. Eur J Gastroenterol Hepatol 1997; 9: 957-62.
31. Annibale B, Marignani M, Azzoni C, et al. Atrophic body gastritis: Distinct features associated with Helicobacter pylori infection. Helicobacter 1997; 2: 57-64.
32. Bruno M, Peyre S, Grosso R, Rizzi R, Sategna-Guidetti C. A twelve-month follow-up after Helicobacter pylori eradication. Panminerva Med 1996; 38: 139-44.
33. Solcia E, Fiocca R, Villani L, Carlsson J, Rudback A, Zeijlon L. Effects of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics. Scand J Gastroenterol 1996; 31(Suppl. 215): 105-10.
34. Gisbert JP, Boixeda D, Vila T, et al. Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori. Scand J Gastroenterol 1996; 31: 103-10.
35. Bianchi Porro G, Lazzaroni M, Bargiggia S, et al. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. Am J Gastroenterol 1996; 91: 695-700.
36. Witteman EM, Mravunac M, Becx MJCM, et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol 1995; 48: 250-6.
37. Stolte M, Bätz, CH, Bayerdörffer E, Edit S. Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach. Z Gastroenterol 1995; 33: 198-201.
38. Solcia E, Villani L, Fiocca R, et al. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 1994; 29(Suppl. 201): 28-34.
39. Trespi E, Broglia F, Villani L, Luinetti O, Fiocca R, Solcia E. Distinct profiles of gastritis in dyspepsia subgroups. Scand J Gastroenterol 1994; 29: 884-8.
40. Wagner S, Haruma K, Gladziwa U, et al. Helicobacter pylori infection and serum pepsinogen A. pepsinogen C and gastrin in gastritis and peptic ulcer: Significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 1994; 89: 1211-8.
41. Yasunaga Y, Shinomura Y, Kanayam S, et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis, Gut 1994; 35: 1571-4.
42. Genta RM, Lew GM, Graham DY, Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993; 6: 281-9.
43. Resende LMH, Queiroz DMM, Barbosa AJA, et al. Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori. Braz J Med Biol Res 1993; 26: 1279-89.
44. Di Napoli A, Petrino R, Boero M, Bellis D, Chiandussi L. Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori. J Clin Pathol 1992; 45: 796-8.
45. Rühl GH, Börsch G. Chronic active gastritis after eradication of Campylobacter (now: Helicobacter) pylori, Path Res Pract 1991; 187: 226-34.
46. Valle J, Seppälä K, Sipponen P, Kosunen T. Disappearance of gastritis after eradication of Helicobacter pylori. Scand J Gastroenterol 1991; 26: 1057-65.
47. Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus - Evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999; 13: 155-62.
48. Hayat M, Arora DS, Dixon MF, Clark B, O'Mahony S. Effects of Helicobacter pylori eradication on natural history of lymphocytic gastritis. Gut 1999; 45: 495-8.
49. Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 1996; 11: 670-3.
50. Miehlke S, Bayerdörffer E, Lehn N, et al. Severity of Helicobacter pylori gastritis predicts duodenal ulcer recurrence. Scand J Gastroenterol 1996; 31: 856-62.
51. Lewy-Trenda I, Trenda P, Wierzchniewska A. Non-ulcer dyspepsia and Helicobacter pylori infection - Morphological analysis according to the Sydney System - Changes before and after treatment. Pol J Pathol 1996; 47: 57-63.
52. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori. Gastroenterology 2000; 118: 22-30.
53. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24.
54. Morales TG, Sampliner RE, Camargo E, Marquis S, Garewal HS, Fennerty BM. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication. J Clin Gastroenterol 2001; 32: 400-4.
55. Antoš D, Enders G, Rieder G, Stolte M. Bayerdörffer E. Hatz RA. Inducible nitric oxide synthase expression before and after eradication of Helicobacter pylori in different forms of gastritis. FEMS Immunol Med Microbiol 2001; 30: 127-321.
56. Kim N, Lim SH, Lee KH, et al. Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers. Dig Dis Sci 2000; 45: 1754-62.
57. Ciok J, Dzieniszewski J, Lucer C. Helicobacter pylori eradication and antral intestinal metaplasia - Two years follow-up study, J Physiol Pharmacol 1997; 48(Suppl. 4): 115-22.
58. Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: Pathogenesis and definition of gastric atrophy. Gastroenterology 1997; 113: S51-5.
59. El-Zimaity HMT, Graham DY, Al-Assi MT, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996; 27: 35-41.
60. Talley NJ. A critique of therapeutic trials in Helicobacter pyloripositive functional dyspepsia. Gastroenterology 1994; 106: 1174-83.
61. Genta RM. Review article: gastric atrophy and atrophic gastritis - Nebulous concepts in search of a definition. Aliment Pharmacol Ther 1998; 12(Suppl. 1): 17-23.
62. Kokkola A, Sipponen P, Rautelin H, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002; 16: 515-20.
63. Jaskiewicz K, Louw JA, Marks IN. Long-term histologic consequences of suppression/eradication of Helicobacter pylori in antral mucosa. Eur J Gastroenterol Hepatol 1993; 5: 701-5.
64. Correa P, Cuello C, Fajardo LF, Haenszel W, Bolaños O, de Ramfrez B, Diet and gastric cancer: Nutrition survey in a high-risk area. J Natl Cancer Inst 1983; 70: 673-8.
65. Basso D, Gallo N, Zambon CF, et al. Antigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammation. Int J Clin Lab Res 2000; 30: 173-8.